| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Cerulean Pharma (CERU) | Leerink Partners | $75.00 | n.a. | |||
| K2M Group Holdings (KTWO) | Piper Jaffray/ Barclays/ Wells Fargo Securities | $100.00 | n.a. | |||
| Leju Holdings Limited (LEJU) | Credit Suisse/ J.P. Morgan | $200.00 | n.a. | |||
| Lombard Medical (LMT) | Jefferies/ Barclays | $80.00 | n.a. | |||
| Papa Murphy’s Holdings (FRSH) | Jefferies/ Baird/ Wells Fargo Securities | $70.00 | n.a. | |||
| Paycom Software (PAYC) | Barclays/ J.P. Morgan | $100.00 | n.a. | |||
| Phibro Animal Health (PAHC) | BofA Merrill Lynch/ Morgan Stanley/ Barclays | $230.00 | n.a. | |||
| Synchrony Financial (SYF) | Goldman Sachs/ J.P. Morgan/ Citigroup/ Morgan Stanley/ Barclays/ BofA Merrill Lynch/ Credit Suisse/ Deutsche Bank Securities | $100.00 | n.a. | |||
| Trinseo S.A. (TSE) | Goldman Sachs/ Deutsche Bank Securities/ Citigroup/ Morgan Stanley/ Barclays/ BofA Merrill Lynch/ HSBC/ Jefferies/ Mizuho Securities/ Scotiabank/ SMBC Nikko/ Wells Fargo Securities | $200.00 | n.a. | |||
| TriVascular Technologies (TRIV) | J.P. Morgan/ Credit Suisse | $100.00 | n.a. | |||
| Vital Therapies (VTL) | BofA Merrill Lynch/ Credit Suisse | $100.00 | n.a. | |||
| Weibo (TBA) | Goldman Sachs (Asia)/ Credit Suisse | $500.00 | n.a. | |||
| Zoe’s Kitchen (ZOES) | Jefferies/ Piper Jaffray/ Baird | $80.50 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| Diamond S Shipping Group (DSG) | Jefferies/ BofA Merrill Lynch | 14.00 | $14.00 | $16.00 | $210.00 | 2-Stars |
| Withdrawn | ||||||
| Waypoint Homes Realty Trust (WAY) | Citigroup/Jefferies | $100.00 | 1-Star | |||
| New Terms | ||||||
| A10 Networks (ATEN) | Morgan Stanley/ BofA Merrill Lynch/ J.P. Morgan Securities/ RBC Capital Markets | 12.50 | $13.00 | $15.00 | $175.00 | 3-Stars |
| Applied Genetic Technologies (AGTC) | BMO Capital Markets/ Wedbush PacGrow Life Sciences | 3.75 | $13.00 | $15.00 | $52.51 | n.a. |
| Bluerock Residential Growth REIT (BRG) | Wunderlich Securities | 3.33 | $15.00 | $15.00 | $50.00 | 1-Star |
| Borderfree (BRDR) | Credit Suisse/ RBC Capital Markets/ Pacific Crest Securities | 5.00 | $14.00 | $16.00 | $75.00 | 3-Stars |
| Castlight Health (CSLT) | Goldman Sachs/ Morgan Stanley | 11.10 | $13.00 | $15.00 | $155.40 | 3-Stars |
| Globoforce Ltd (THNX) | J.P. Morgan/ Credit Suisse/ UBS Investment Bank/ Stifel | 4.41 | $16.00 | $18.00 | $75.00 | 3-Stars |
| King Digital Entertainment plc (KING) | J.P. Morgan/ Credit Suisse/ BofA Merrill Lynch/ Barclays/ Deutsche Bank/ RBC Capital Markets | 22.20 | $21.00 | $24.00 | $499.50 | 3-Stars |
| Nord Anglia Education (NORD) | Credit Suisse/ Goldman Sachs/ J.P. Morgan | 19.00 | $15.00 | $17.00 | $304.00 | 2-Stars |
| Ruthigen (RTGN) | Dawson James Securities | 2.20 | $7.25 | $9.25 | $18.15 | 1-Star |
| Square 1 Financial (SQBK) | Sandler ONeill & Partners/ Keefe, Bruyette & Woods (A Stifel Company) | 5.88 | $15.00 | $17.00 | $94.10 | n.a. |
| TriNet Group (TNET) | J.P. Morgan/ Morgan Stanley/ Deutsche Bank Securities | 15.00 | $15.00 | $17.00 | $240.00 | 3-Stars |
| Versartis (VSAR) | Morgan Stanley/ Citigroup | 4.60 | $16.00 | $19.00 | $80.50 | 2-Stars |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of March 10, 2014 | Manager(s) | Offered | Raised | Price | 3/14/14 | Change |
| Castlight Health (CSLT) | Goldman Sachs/ Morgan Stanley | 11.10 | $177.60 | $16.00 | $39.80 | 148.75% |
| Achaogen (AKAO) | Credit Suisse/ Cowen and Company | 6.00 | $72.00 | $12.00 | $16.16 | 34.67% |
| Dipexium Pharmaceuticals (DPRX) | Oppenheimer & Co. | 2.75 | $33.00 | $12.00 | $13.40 | 11.67% |
| Galmed Pharmaceuticals Ltd. (GLMD) | Maxim Group LLC | 2.84 | $38.30 | $13.50 | $14.65 | 8.52% |
